a*u
发帖数: 2334 | 1 http://www.istockanalyst.com/article/viewarticlepaged/articleid/4484921/pageid/1
There is Tongjitang Chinese Medicines ADR (NYSE: TCM). But it depends
heavily on a single medicine, XLGB, its barrenwort treatment for
osteoporosis.
Since the U.S. doesn't understand traditional Chinese medicines very well,
the stock has done poorly. And because of that, there is a current buyout
offer for the company by its chairman and Hong Kong conglomerate Fosun
Industrial, at $4.50 a share. |
|
